04.01.13
Nestlé Health Science, a fully owned subsidiary of Nestlé, has agreed to acquire the business of Pamlab, a Covington, LA-based company with a portfolio of medical food products for use under medical supervision in the nutritional management of patients with mild cognitive impairment, depression and diabetic peripheral neuropathy. The acquisition further strengthens Nestlé Health Science’s capacity to deliver personalized healthcare to address chronic medical conditions through nutrition, especially in the areas of metabolic health and brain health.
Pamlab’s portfolio of prescription medical food products for use under medical supervision includes Metanx, a key product that is formulated to meet the distinct nutritional requirements of patients with diabetes to help restore the metabolic processes associated with peripheral neuropathy. Pamlab also makes Deplin, a medical food specifically formulated to provide necessary nutritional support for certain people on prescribed antidepressant therapy for clinical depression. In addition, the company produces CerefolinNAC, a medical food to help address distinct metabolic nutritional needs associated with mild cognitive impairment.
In other news at Nestlé, the company has published a set of forward-looking commitments involving nutrition, environment sustainability and other areas it aims to meet by 2020 or earlier. Nestlé has identified 30 goals in the areas of nutrition, water, rural development, sustainability and compliance in its new report, “Nestlé in Society: Creating Shared Value and Meeting our Commitments 2012.”
The time-bound targets reflect Nestlé’s ambitions to work collectively with other stakeholders to help address the global food and water crisis, and the specific nutritional challenges posed by malnutrition, including micronutrient deficiencies.
Some of the key goals include: Providing 200 billion servings of micronutrient fortified products worldwide by 2016, with a special focus on children and women of childbearing age; Ensuring all relevant products worldwide have guideline daily amount (GDA) labeling on front of pack by 2016; Ensuring all children’s products meet the Nestlé Nutritional Foundation criteria for children by 2014; Providing portion guidance on all children’s and family products by 2015; Reducing direct water withdrawal per ton of product by 40% compared to 2005 by 2015; Achieving 100% certified responsibly sourced, sustainable palm oil by the end of 2013, two years ahead of its initial public commitment; Reducing direct greenhouse gas emissions per ton of product by 35% compared to 2005, by 2015.
Pamlab’s portfolio of prescription medical food products for use under medical supervision includes Metanx, a key product that is formulated to meet the distinct nutritional requirements of patients with diabetes to help restore the metabolic processes associated with peripheral neuropathy. Pamlab also makes Deplin, a medical food specifically formulated to provide necessary nutritional support for certain people on prescribed antidepressant therapy for clinical depression. In addition, the company produces CerefolinNAC, a medical food to help address distinct metabolic nutritional needs associated with mild cognitive impairment.
In other news at Nestlé, the company has published a set of forward-looking commitments involving nutrition, environment sustainability and other areas it aims to meet by 2020 or earlier. Nestlé has identified 30 goals in the areas of nutrition, water, rural development, sustainability and compliance in its new report, “Nestlé in Society: Creating Shared Value and Meeting our Commitments 2012.”
The time-bound targets reflect Nestlé’s ambitions to work collectively with other stakeholders to help address the global food and water crisis, and the specific nutritional challenges posed by malnutrition, including micronutrient deficiencies.
Some of the key goals include: Providing 200 billion servings of micronutrient fortified products worldwide by 2016, with a special focus on children and women of childbearing age; Ensuring all relevant products worldwide have guideline daily amount (GDA) labeling on front of pack by 2016; Ensuring all children’s products meet the Nestlé Nutritional Foundation criteria for children by 2014; Providing portion guidance on all children’s and family products by 2015; Reducing direct water withdrawal per ton of product by 40% compared to 2005 by 2015; Achieving 100% certified responsibly sourced, sustainable palm oil by the end of 2013, two years ahead of its initial public commitment; Reducing direct greenhouse gas emissions per ton of product by 35% compared to 2005, by 2015.
